|
|
|
Volumn 59, Issue SUPPL. 5, 1998, Pages 3-4
|
|
Augmentation of antidepressant medication
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMFEBUTAMONE;
ANTIDEPRESSANT AGENT;
BUPRENORPHINE;
CLOZAPINE;
FLUOXETINE;
FLUVOXAMINE;
FLUVOXAMINE MALEATE;
MIRTAZAPINE;
NEFAZODONE;
PAROXETINE;
SERTRALINE;
VENLAFAXINE;
ANTICONVULSIVE AGENT;
BUSPIRONE;
CALCIUM CHANNEL BLOCKING AGENT;
LITHIUM;
PINDOLOL;
THYROID HORMONE;
DEPRESSION;
DRUG EFFECT;
DRUG SAFETY;
DRUG TOLERABILITY;
HUMAN;
NOTE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
ARTICLE;
DRUG COMBINATION;
DRUG POTENTIATION;
TREATMENT OUTCOME;
ANTICONVULSANTS;
ANTIDEPRESSIVE AGENTS;
BUSPIRONE;
CALCIUM CHANNEL BLOCKERS;
DEPRESSIVE DISORDER;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
HUMANS;
LITHIUM;
PINDOLOL;
THYROID HORMONES;
TREATMENT OUTCOME;
|
|
EID: 0031866540
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (11)
|
|
References (0)
|
